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ABSTRACT: Recently, our group demonstrated that mouse lesions in-
fected with Leishmania amazonensis are hypoxic. Evidence indicates
the negative impact of hypoxia on the efficacy of a variety of chemo-
therapeutic agents against tumors, fungi, bacteria, and malaria parasites.
In the present study, comparison of the effect of antileishmanial drugs
on L. amazonensis-infected macrophages under normoxic and hypoxic
conditions was performed. We compared the effect of 5% oxygen ten-
sion with a tension of 21% oxygen on peritoneal murine macrophage
cultures infected with the parasite and treated with glucantime, ampho-
tericin B, or miltefosine. Analysis of the infection index (percentage of
infected macrophages  number of amastigotes per macrophage), dose-
dependent efficacy of drugs, and IC50 values demonstrated that hypoxia
conferred a small, but significant, resistance to all 3 antileishmanial
drugs. The present finding suggests that in vitro assays under hypoxia
should not be neglected in drug studies.
Leishmaniasis is a neglected disease caused by several species of
Leishmania; it is currently endemic in 88 countries (Desjeux, 2004).
The severity of the disease produced by several Leishmania species
varies enormously, ranging from cutaneous or mucosal to visceral or
diffuse cutaneous infection. The former is generally caused by Leish-
mania amazonensis, a species transmitted mainly in the Amazon region
of South America, which is associated with localized cutaneous lesions
(Grimaldi and Tesh, 1993). Current therapies frequently fail to eradicate
the parasite from infected tissues, while also presenting serious side
effects (Berman, 2003). The first line of therapy for all forms of the
disease is pentavalent antimonial (Sbv), sodium stibogluconate, and
meglumine antimoniate glucantime (Berman, 2003). The polyene anti-
biotic amphotericin B and diamidine pentamidine are second-line drugs,
and miltefosine, a lysophospholipid analog, is the most recent drug ap-
proved for leishmaniasis treatment (Berman, 2003; Mishra et al., 2007).
Leishmania spp. are protozoan parasites that replicate in mammalian
cells, principally in macrophages (Desjeux, 2004).
Several characteristics of the disease include microcirculatory im-
pairment, parasite proliferation, secondary bacterial infection, and ex-
pression of hypoxia-inducible transcription factor-1 in the murine cu-
taneous lesions infected with L. amazonensis. These features are strong
indications of a reduced intralesional oxygen tension (hypoxia) (El-On
et al., 1992; Grimaldi and Tesh, 1993; Arrais-Silva et al., 2005). In fact,
hypoxia is a primary attribute of tissues experiencing infection, inflam-
mation, or tumor cell proliferation (Ikeda, 2005). The effectiveness of
drugs such as amphotericin B against Candida albicans, aminoglyco-
side antibiotics against Escherichia coli, antibiotics and antimalarial
products against Plasmodium falciparum, and alkylating agents against
tumor cells under hypoxic conditions has been investigated experimen-
tally (Divo et al., 1985; Sokol-Anderson et al., 1986; Krungkrai and
Yuthavong, 1987; Bryant et al., 1992; Brown, 2002; Koch et al., 2003;
Grigoryan et al., 2005; Cao et al., 2007). Under hypoxic conditions,
these drugs were less effective. To the best of our knowledge, no in-
formation is available for the effect of hypoxia on the efficacy of an-
tileishmanial drugs. In the present study, the efficiency of glucantime,
amphotericin B, and miltefosine on L. amazonensis-infected macro-
phages under normoxic and hypoxic conditions were evaluated.
Leishmania amazonensis (MHOM/BR/73/M2269) amastigotes were
isolated from active skin lesions of BALB/c mice as described previ-
ously (Colhone et al., 2004). Primary mouse macrophages were ob-
tained from normal BALB/c mice by peritoneal lavage as described
previously, cultured in 24-well cell culture plates containing 13-mm-
diameter glass coverslips (5  105 cells per well), and maintained in
RPMI medium supplemented with antibiotics and 10% heat-inactivated
fetal calf serum (Colhone et al., 2004). Macrophages were exposed to
L. amazonensis at a parasite–macrophage ratio of 3:1 for 2 hr. After the
exposure period, the cultures were washed to remove extracellular par-
asites and then incubated in the presence of different concentrations of
the drugs at 37 C for 48 hr. For the evaluation of the infection index
(IF) (percentage of infected macrophages  number of amastigotes per
macrophage), cells on coverslips were stained with Giemsa and exam-
ined microscopically at 1,000 magnification (Colhone et al., 2004).
The drug concentration that caused a 50% reduction in IF (IC50) was
estimated by regression analyses using SigmaPlot 2001 (Systat Software
Inc., San Jose, California). All experiments were repeated at least 3
times in triplicate wells, and the results are expressed as the mean 
SD. Statistical analyses were performed using the 2-tailed Student’s
t-test and Origin 6.0 (OriginLab Corp., Northampton, Massachusetts).
A P  0.05 value was considered to be significant.
Hypoxic cell culture conditions were established, as described pre-
viously (Colhone et al., 2004). The plates containing L. amazonensis-
infected macrophage cultures were placed in a gas-tight modular cham-
ber (Billups-Rothenberg, Del Mar, California). In all experiments, the
exposure of cells to 5% O2, 5% CO2 and balanced N2 is referred to as
hypoxia, and the exposure of cells to 21% O2, 5% CO2 and balanced
N2 is referred to as normoxia (Colhone et al., 2004). The oxygen tension
in the culture medium was 37 mm Hg under hypoxia conditions and
150 mm Hg under normoxia condition (O2 analyzer YSI/53, YSI Inc.,
Yellow Springs, Ohio). The medium pH was 7.4 and did not change
significantly during the course of the experiments. Glucantime (penta-
valent antimony: N-methyl glucamine antimonate) (Aventis Pharma,
São Paulo, Brazil) was diluted in RPMI medium; amphotericin B (Sig-
ma-Aldrich, St. Louis, Missouri) and miltefosine (hexadecylphospho-
choline) (Cayman Chemical, Ann Arbor, Michigan) were prepared in
phosphate-buffered saline just before use.
To assess the effects of low oxygen tension on the efficacy of anti-
leishmanial reference drugs, the infection index values (percentage of
infected macrophages  number of amastigotes per macrophage), and
the IC50 values obtained in L. amazonensis-infected macrophage cul-
tures treated with drugs and maintained in normoxic or hypoxic con-
ditions were evaluated and compared.
As expected, under normoxic conditions, glucantime, amphotericin
B, and miltefosine were found to be toxic to intracellular parasites and
exhibited dose-dependent efficacy in a 48-hr intracellular amastigote
assay (Fig. 1). Under normoxic conditions, the mean IC50 value of glu-
cantime, amphotericin B, and miltefosine was 30.4, 0.40, and 16.0 g/
ml, respectively (Table I). These data are consistent with previously
reported results (Callahan et al., 1997; Santa-Rita et al., 2004). Exposure
of L. amazonensis-infected macrophage cultures to hypoxia increased
resistance to various concentrations of drugs, significantly (Fig. 1). Hyp-
oxia caused a modest, but statistically significant, effect on the IC50
values of all the drugs tested (Table I). The IC50 value of glucantime
against L. amazonensis-infected macrophages maintained in hypoxia in-
creased 1.5-fold compared with normoxic conditions. The increase in
IC50 values under hypoxia compared with normoxia was 1.25 for am-
photericin B and 2.12 for miltefosine (Table I).
Previous evidence regarding the negative impact of hypoxia on the
efficacy of a variety of chemotherapeutic agents (with unrelated modes
of action) have been provided in numerous studies (Sokol-Anderson et
al., 1986; Bryant et al., 1992; Teicher, 1994; Brown, 2002; Koch et al.,
2003; Hyun et al., 2004; Grigoryan et al., 2005; Song et al., 2006; Cao
et al., 2007). For example, the IC50 values of cisplatin, oxaplatin, gem-
citabine, etoposide (Etopophos), bleomycin, mitomycin C, irinotecan,
and paclitaxel show a greater than 5-fold increase under hypoxia against
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FIGURE 1. Effect of hypoxia on Leishmania amazonensis-infected
macrophages treated with antileishmanial drugs. Murine peritoneal mac-
rophages were infected with L. amazonensis amastigotes for 2 hr. Cell
cultures were washed and immediately treated with glucantime (A),
amphotericin B (B), or miltefosine (C), under normoxic () or hypoxic
() conditions for 48 hr. The percentage of control values were cal-
TABLE I. Mean values of IC50 in normoxia and hypoxia of antileish-
manial drugs*.
Drug





Glucantime† 30.4  4.8 43.5  1.2 1.50
Amphotericin B 0.40  0.01 0.50  0.01 1.25
Miltefosine 16.0  2.72 34.0  3.15 2.12
* The IC50 values for a 48-hr intracellular L. amazonensis amastigote assay.
† Values for the antimonial agent glucantime are in micrograms of Sb per milli-
liter.
←
culated by dividing infection index in the presence of drug with infec-
tion index in the absence of drug and multiplying by 100. The results
represent the mean  SD of 3 experiments. The significance of the
difference between cell cultures in hypoxia and normoxia is indicated
in the figure. *P  0.05.
human embryonal carcinomas (Koch et al., 2003). Hypoxia confers a
2-fold higher resistance to daunorubicin in colon cancer cells lines (Cao
et al., 2007), and one report found that amphotericin B-induced C. al-
bicans protoplast lysis showed a 5-fold reduction at a concentration of
2 g/ml of amphotericin B in a hypoxic atmosphere (Sokol-Anderson
et al., 1986).
Although there is no previous investigation of the effect of hypoxia
on the efficacy of drugs against trypanosomatid parasites, an oxygen-
dependent effect of a variety of antibiotics and artemisinin, an anti-
malarial herb product, has been reported on P. falciparum in culture
(Divo et al., 1985; Krungkrai and Yuthavong, 1987). The authors did
not correlate low potency of drugs in hypoxic conditions with clinical
and pathological circumstances; instead, they concluded that the com-
pounds increasing the oxidant stress on the parasite and infected red
cells.
In the present study, hypoxia displayed a small, but significant, effect
on the IC50 values of glucantime, amphotericin B, and miltefosine for
L. amazonensis amastigotes within macrophages. Although the exact
modes of action of these antileishmanial drugs are yet to be completely
defined, their mechanisms have been considered to be nonoverlapping.
Pentavalent antimonials are generally regarded as prodrugs that require
conversion to the trivalent form (SbIII), which inhibits glycolysis, mac-
romolecular biosynthesis, and trypanothione reductase activity (Wyllie
et al., 2004). It is accepted that the damaging action of amphotericin B
to Leishmania spp. originates from its binding to ergosterol, the major
sterol incorporated into the cell membrane by the parasite, presenting
the immediate consequence of membrane disorganization and depolar-
ization (Beggs, 1994). The mode of action of miltefosine has been as-
sociated with perturbation of the alkylphospholipid metabolism, biosyn-
thesis of alkyl-anchored glycolipids, and glycoproteins and apoptosis-
like death in the parasite (Lux et al., 2000).
Because hypoxia has been shown to induce relative resistance to a
broad spectrum of cytotoxic agents with unrelated modes of action, it
has been suggested that this resistance may be caused by altered sta-
bility of the drug molecule in a hypoxic microenvironment (Teicher,
1994; Koch et al., 2003; Grigoryan et al., 2005). Furthermore, the hyp-
oxia effect may be caused by a defective uptake mechanism in the cell.
This may be the case for antileishmanial compounds; thus, macrophages
under hypoxia may concentrate less drug within the parasitophorous
vacuole harboring the parasites. Hypoxia can also lead to relative drug
resistance through indirect effects via altered cellular metabolism, which
decreases drug cytotoxicity (Teicher, 1994).
In summary, the data reported here show that hypoxia confers a rel-
ative resistance to antileishmanial drugs and suggests that in vitro assays
under normoxia might overestimate the novel and potential antileish-
manial drugs. Although the clinical relevance of the present results and
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experiments using different Leishmania species need to be considered
further, the present study indicates that hypoxia, a condition associated
with tumors, inflammation, and infections, should not be neglected in
drug studies.
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